PRCT vs XLK
Procept Biorobotics Corp (PRCT) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported PRCT revenue for 2026-06-30 was $177.6M. Net income was -$58.5M. PRCT currently screens at market cap $1.52B.
XLK does not have a complete income-statement cache yet.
PRCT currently screens at market cap $1.52B. XLK currently screens at market cap $0.
Not investment advice. Open the PRCT and XLK stock pages for the full models.
Not investment advice.